September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025
Jun 1, 2025, 06:00

Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025

Margherita Ambrosini, Medical Doctor, Oncology Clinical and Research Fellow at the Fondazione IRCCS National Cancer Institute in Milan, posted on LinkedIn:

“Switch maintenance with paclitaxel plus ramucirumab significantly improved key disease related symptoms and delayed clinical deterioration compared to continuation of oxaliplatin and fluoropyrimidine first line chemotherapy in patients with advanced HER2- gastric/gej cancer enrolled in the phase 3 ARMANI trial.
Pass by poster board 350 to discuss about it!”
Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025

More posts featuring ASCO25.